Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Sipurui Pharmaceutical Technology is a China-based biotechnology company focused on the research and development of innovative small molecule therapeutics. Founded in 2014 and headquartered in Shanghai, the company specializes in medicinal chemistry, process optimization, and pharmaceutical technology transfer. Sipurui's research efforts are primarily directed toward oncology and metabolic disorders, utilizing a robust R&D platform to develop novel drug candidates. In addition to its internal pipeline, the company provides technical consulting and collaborative R&D services to global and domestic pharmaceutical partners. Sipurui operates within the vibrant Shanghai life sciences ecosystem, emphasizing high-quality chemical synthesis and innovative drug design.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Sipurui Pharmaceutical Technology.